Premal H. Thaker - Concepedia

Author

Premal H. Thaker

Washington University in St. Louis ORCID

Also Known As

McMeekin, D. Scott, P H Thaker, P Thaker, P. H. Thaker, P. Thaker, P.H. Thaker, PREMAL H. THAKER, Pankil Thaker, Pooja Thaker, Poojan Hasmukhray Thaker

759

Publications

10.2K

Citations

H-Index

123

Concepts

All Affiliations

Washington University in St. Louis The University of Texas MD Anderson Cancer Center University of Iowa Gynecologic Oncology Group Roswell Park Comprehensive Cancer Center

About

Premal H. Thaker is an author at Washington University in St. Louis specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	69	4.5K
2	Public Health	10	10	408
3	Health Sciences	9	9	1.6K
4	Nursing	4	4	91
5	Education	1	1	11

Premal H. Thaker

146

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma Premal H. Thaker, Liz Y. Han, Aparna A. Kamat, Nature Medicine MedicineMouse ModelCell ProliferationOvarian CarcinomaRadiation Oncology	2006	1.3K
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer Ramez N. Eskander, Michael W. Sill, Lindsey Beffa, New England Journal of Medicine	2023	626
Stress Hormone–Mediated Invasion of Ovarian Cancer Cells Anil K. Sood, Robert Bhatty, Aparna A. Kamat, Clinical Cancer Research	2006	478
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022 Deborah K. Armstrong, Ronald D. Alvarez, Floor Backes, Journal of the National Comprehensive Cancer Network Nccn Guidelines® InsightsTumoral PathologyEndocrine-related CancerEpithelial Ovarian CancerMedicine	2022	369
Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer Saketh R. Guntupalli, Israel Zighelboim, Nora T. Kizer, Gynecologic Oncology Gynecological SurgeryPoor OutcomesMedicineEndometrioid Endometrial CancerGynecology	2011	211
EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma Premal H. Thaker, Michael T. Deavers, Joseph Celestino, Clinical Cancer Research	2004	211
Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer Jack L. Watkins, Premal H. Thaker, Alpa M. Nick, Cancer	2015	190
Social Influences on Clinical Outcomes of Patients With Ovarian Cancer Susan K. Lutgendorf, Koen De Geest, David Bender, Journal of Clinical Oncology	2012	169
Functional significance of VEGFR‐2 on ovarian cancer cells Whitney A. Spannuth, Alpa M. Nick, Nicholas B. Jennings, International Journal of Cancer	2008	149
Metronomic Chemotherapy Enhances the Efficacy of Antivascular Therapy in Ovarian Cancer Aparna A. Kamat, Tae Jin Kim, Charles N. Landen, Cancer Research	2007	147

Page 1